Sensitization of human cells to lysis by human complement as an approach for cancer gene therapy

Adv Exp Med Biol. 1998:451:359-63. doi: 10.1007/978-1-4615-5357-1_56.

Authors

U Jäger¹, Y Takeuchi, C D Porter

Affiliation

¹ Institute of Cancer Research, Gene Therapy Group, London, United Kingdom. [email protected]

PMID: 10026897
DOI: 10.1007/978-1-4615-5357-1_56

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

3T3 Cells
Animals
Cell Line
Cell Membrane / physiology
Complement System Proteins / physiology*
Disaccharides / biosynthesis*
Galactosyltransferases / genetics*
Galactosyltransferases / metabolism
Genetic Therapy / methods*
Genetic Vectors
Humans
Melanoma / immunology*
Mice
Phosphatidylinositol Diacylglycerol-Lyase
Retroviridae
Tumor Cells, Cultured
Type C Phospholipases / metabolism

Substances

Disaccharides
galactosyl-(1-3)galactose
Complement System Proteins
Galactosyltransferases
N-acetyllactosamine alpha-D-galactosyltransferase
Type C Phospholipases
Phosphatidylinositol Diacylglycerol-Lyase